Pharmacy

Pfizer's breast cancer drug Ibrance did not meet its goal of improving invasive disease-free survival in patients with early-stage breast cancer, the drugmaker announced Oct. 9.

Johnson & Johnson voluntarily paused the clinical trial for its COVID-19 vaccine candidate Oct. 12 after learning of a participant's unexplained illness, STAT reported.

Ten hospitals and health systems posted job listings seeking pharmacy leaders in the last week.

Several national pharmacy associations are celebrating Women Pharmacist Day Oct. 12, a day created by Suzanne Soliman, PharmD, to honor female trailblazers in the pharmacy profession. 

After the FDA said in May that it found unacceptable levels of a carcinogen in popular diabetes drug metformin, several drugmakers began recalling their metformin products. 

The National Institutes of Health has begun studying remdesivir in combination with a highly concentrated solution of COVID-19 antibodies to see if it can reduce the risk of patients developing more serious illness. 

HHS will pay pharma giant AstraZeneca $486 million to secure as many as 100,000 doses of its experimental COVID-19 antibody drug, as well as support clinical trials for the treatment.

Moncef Slaoui, PhD, the chief advisor of Operation Warp speed, the White House task force to develop a COVID-19 vaccine, said drugmakers developing COVID-19 vaccines will begin to seek FDA emergency approval around Thanksgiving, according to an Oct. 10 MarketWatch…

Mallinckrodt has filed for Chapter 11 bankruptcy for all of its U.S. subsidiaries and some international subsidiaries, the company said Oct. 12. 

The race to develop a COVID-19 vaccine will most likely bring about the most rapidly developed vaccine in history, but uncertainties still abound when it comes to a potential vaccine's effectiveness, safety and ability to be administered to the world's…